GST RELIEF MECHANISMS FOR PATIENTS UNABLE TO OBTAIN ESSENTIAL MEDICATION FROM PUBLIC HEALTHCARE INSTITUTIONS DUE TO SYSTEMIC AVAILABILITY CONSTRAINTS

NOTICE PAPER NO. 588

NOTICE OF QUESTION FOR WRITTEN ANSWER

FOR THE SITTING OF PARLIAMENT ON 4 MARCH 2026

Name and Constituency of Member of Parliament

Dr Hamid Razak

MP for West Coast-Jurong West

Question No. 1180

To ask the Coordinating Minister for Social Policies and Minister for Health (a) whether the Ministry has assessed the GST treatment of medically indicated medications that are unavailable in public healthcare institutions, requiring patients to obtain them privately; and (b) whether any policy mechanisms exist or are under consideration to address GST burdens arising from such systemic availability constraints.

Answer

1.       Subsidised patients who obtain medications at Public Healthcare Institutions (PHIs) for their care will have their GST incurred fully absorbed by the Government.

2.       If a patient requires a medication that is unavailable in one PHI, the PHI can check to see if the medication is available at other PHIs. If not immediately available, PHIs may exercise discretion to procure these medications for the patient or assess the suitability of alternative treatments. Hence, PHIs would not require subsidised patients to obtain medically indicated medications from private sources in the vast majority of cases.